Cell Banking Outsourcing Market Introduction and Overview
According to SPER Market Research, the Global Cell Banking Outsourcing Market is estimated to reach USD 56.71 billion by 2033 with a CAGR of 16.5%.
The report includes an in-depth analysis of the Global Cell Banking Outsourcing Market, including market size and trends, product mix, Applications, and supplier analysis. A cell bank is a kind of facility where cells from different organs and bodily fluids are kept for later use. Cross-contamination is less likely because the cells are housed with thorough cell line characterisation. Cell banking outsourcing includes the storage, gathering, characterisation, and testing of cells, cell lines, and tissues. Cell banks offer tissues, cell lines, and cells for research and development. They also facilitate the creation of biopharmaceuticals with minimal side effects and maximum efficacy.
- September 2021: Mesocel from Life Cell was granted DCGI permission for its clinical trial therapy that uses MSC produced from umbilical cord tissue to treat patients suffering from acute respiratory distress, pneumonia, and COVID-19.
- February 2021: With an initial focus on eye disorders, Paragon Biosciences (US) founded CiRC Biosciences. CiRC Biosciences is a cell therapy firm that develops solutions for diseases with high unmet needs.
- February 2021: BioTherapeutic Labs Corp. and American CryoStem collaborated to do stem cell research and development.
- February 2021: To grow its business segments, Cryo-Cell International, Inc. collaborated with Duke University.
Market Opportunities and Challenges
The market for outsourcing cell banking offers a number of opportunities for development. Cell banking outsourcing providers can benefit greatly from the growing investments in the healthcare sector in emerging markets. These markets provide economic advantages, a sizable patient pool, and hospitable regulatory frameworks. Cell banking services are in high demand as a result of the development of cutting-edge cell therapies including gene and CAR-T cell therapies. Businesses can obtain the knowledge and resources needed for the effective development and application of these treatments by outsourcing cell banking. Access to innovative cell lines and research opportunities can be made available to outsourcing providers through partnerships with universities, research centres, and biopharmaceutical companies. They can grow their clientele and improve the services they offer through strategic alliances.
On the other hand, the outrageous expense of maintaining these cells in cell banks is a major barrier for this industry. It's anticipated that the sector would be constrained by a number of legal concerns around stem cell banking and other forms of cell banking. Furthermore, concerns about the methods used to get potential cord blood donors' informed consent as well as issues with donors' disclosure of important clinical data found during the donor screening process are impeding the growth of the cell banking outsourcing market. Last but not least, handling and storing cells should be done with prudence as one of the risks of cell banking is cell contamination from human mistake or external factors.
Market Competitive Landscape
The market for cell banking outsourcing is moderately competitive. Growing use of cell banking services, the introduction of new biopharmaceutical medications, and the growth of alliances between major businesses are the main factors driving the market. To enhance their market position, major firms in this industry are employing a range of tactics, such as market expansion through geographic expansion, strategic partnerships, and mergers and acquisitions. The major players in the market include: Charles River Laboratories, Inc., Clean Biologics, Cordlife Group Limited, Cryo-Cell International Inc., Cryoviva India, GBI, LifeCell International Pvt. Ltd, Lonza, Merck KGaA, Reliance Life Sciences, SGS Life Sciences, Texcell, Wuxi Apptec, Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type, By Cell Type, By Phase
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Charles River Laboratories, Inc., Clean Biologics, Cordlife Group Limited, Cryo-Cell International Inc., Cryoviva India, GBI, LifeCell International Pvt. Ltd, Lonza, Merck KGaA, Reliance Life Sciences, SGS Life Sciences, Texcell, Wuxi Apptec, Others
|
COVID-19 Impact on Global Cell Banking Outsourcing Market
The industry for cell banking outsourcing has been impacted by the COVID-19 epidemic in both positive and negative ways. Positively, the epidemic has brought attention to how crucial it is to create vaccines and cell-based treatments. This has fuelled the market's expansion and raised demand for mobile banking services. The rising incidence of COVID-19 is anticipated to have a major impact on worldwide cell banking outsourcing during the predicted period. Furthermore, the market for cellular banking outsourcing has been adversely affected by the large losses incurred by numerous regional markets due to the ongoing coronavirus outbreak. The epidemic has, however, also slowed down research and development efforts and upset international supply chains, which has had an impact on the growth of the market as a whole.
Key Target Audience:
- Agricultural and Food Industry
- Biopharmaceutical Companies
- Clinical Research Organizations (CROs)
- Contract Development and Manufacturing Organizations (CDMOs
- Diagnostic Test Developers
- Gene Therapy and Cell Therapy Developers
- Start-up Biotech Companies
- Veterinary and Animal Health Companies
- Others
Our in-depth analysis of the Cell Banking Outsourcing Market includes the following segments:
|
By Type:
|
Master Cell Banking
Viral Cell Banking
Working Cell Banking
|
|
By Cell Type:
|
Stem Cell
Non-stem Cell
|
|
By Phase:
|
Bank Characterization & Testing
Bank Preparation
Bank Storage
|
|
By Region:
|
Asia-Pacific
Europe
Middle East & Africa
North America
Latin America
|
Key Topics Covered in the Report
- Global Cell Banking Outsourcing Market Size (FY’2023-FY’2033)
- Overview of Global Cell Banking Outsourcing Market
- Segmentation of Global Cell Banking Outsourcing Market By Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking)
- Segmentation of Global Cell Banking Outsourcing Market By Cell Type (Stem Cell, Non-stem Cell)
- Segmentation of Global Cell Banking Outsourcing Market By Phase (Bank Characterization & Testing, Bank Preparation, Bank Storage)
- Statistical Snap of Global Cell Banking Outsourcing Market
- Expansion Analysis of Global Cell Banking Outsourcing Market
- Problems and Obstacles in Global Cell Banking Outsourcing Market
- Competitive Landscape in the Global Cell Banking Outsourcing Market
- Impact of COVID-19 and Demonetization on Global Cell Banking Outsourcing Market
- Details on Current Investment in Global Cell Banking Outsourcing Market
- Competitive Analysis of Global Cell Banking Outsourcing Market
- Prominent Players in the Global Cell Banking Outsourcing Market
- SWOT Analysis of Global Cell Banking Outsourcing Market
- Global Cell Banking Outsourcing Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Cell Banking Outsourcing Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Cell Banking Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cell Banking Outsourcing Market
7. Global Cell Banking Outsourcing Market, By Type (USD Million)
7.1. Global Cell Banking Outsourcing Market Value Share and Forecast, By Type, 2023-2033
7.2. Master Cell Banking
7.3. Viral Cell Banking
7.4. Working Cell Banking
8. Global Cell Banking Outsourcing Market, By Cell Type (USD Million)
8.1. Global Cell Banking Outsourcing Market Value Share and Forecast, By Cell Type, 2023-2033
8.2. Stem Cell
8.2.1. Adult Stem Cell Banking
8.2.2. Cord Cell Banking
8.2.3. Dental Stem Cell Banking
8.2.4. Embryonic Stem Cell Banking
8.2.5. IPS Stem Cell Banking
8.3. Non-stem Cell
9. Global Cell Banking Outsourcing Market, By Phase (USD Million)
9.1. Global Cell Banking Outsourcing Market Value Share and Forecast, By Phase, 2023-2033
9.2. Bank Characterization & Testing
9.2.1. Gene Expression Testing
9.2.2. Gene Sequencing Testing
9.2.3. Karyology Testing
9.2.4. Safety Testing
9.3. Bank Preparation
9.3.1. Master Cell Bank Preparation
9.3.2. Working Cell Bank Preparation
9.4. Bank Storage
9.4.1. Cell Storage Stability Testing
9.4.2. Master Cell Bank Storage
9.4.3. Working Cell Bank Storage
10. Global Cell Banking Outsourcing Market Forecast, 2019-2033 (USD Million)
10.1. Global Cell Banking Outsourcing Market Size and Market Share
11. Global Cell Banking Outsourcing Market, By Type, 2019-2033 (USD Million)
11.1. Global Cell Banking Outsourcing Market Size and Market Share By Type (2019-2026)
11.2. Global Cell Banking Outsourcing Market Size and Market Share By Type (2027-2033)
12. Global Cell Banking Outsourcing Market, By Cell Type, 2019-2033 (USD Million)
12.1. Global Cell Banking Outsourcing Market Size and Market Share By Cell Type (2019-2026)
12.2. Global Cell Banking Outsourcing Market Size and Market Share By Cell Type (2027-2033)
13. Global Cell Banking Outsourcing Market, By Phase, 2019-2033 (USD Million)
13.1. Global Cell Banking Outsourcing Market Size and Market Share By Phase (2019-2026)
13.2. Global Cell Banking Outsourcing Market Size and Market Share By Phase (2027-2033)
14. Global Cell Banking Outsourcing Market, By Region, 2019-2033 (USD Million)
14.1. Global Cell Banking Outsourcing Market Size and Market Share By Region (2019-2026)
14.2. Global Cell Banking Outsourcing Market Size and Market Share By Region (2027-2033)
14.3. Asia-Pacific
14.3.1. Australia
14.3.2. China
14.3.3. India
14.3.4. Japan
14.3.5. South Korea
14.3.6. Rest of Asia-Pacific
14.4. Europe
14.4.1. France
14.4.2. Germany
14.4.3. Italy
14.4.4. Spain
14.4.5. United Kingdom
14.4.6. Rest of Europe
14.5. Middle East and Africa
14.5.1. Kingdom of Saudi Arabia
14.5.2. United Arab Emirates
14.5.3. Rest of Middle East & Africa
14.6. North America
14.6.1. Canada
14.6.2. Mexico
14.6.3. United States
14.7. Latin America
14.7.1. Argentina
14.7.2. Brazil
14.7.3. Rest of Latin America
15. Company Profile
15.1. Charles River Laboratories, Inc.
15.1.1. Company details
15.1.2. Financial outlook
15.1.3. Product summary
15.1.4. Recent developments
15.2. Clean Biologics
15.2.1. Company details
15.2.2. Financial outlook
15.2.3. Product summary
15.2.4. Recent developments
15.3. Cordlife Group Limited
15.3.1. Company details
15.3.2. Financial outlook
15.3.3. Product summary
15.3.4. Recent developments
15.4. Cryo-Cell International Inc.
15.4.1. Company details
15.4.2. Financial outlook
15.4.3. Product summary
15.4.4. Recent developments
15.5. Cryoviva India
15.5.1. Company details
15.5.2. Financial outlook
15.5.3. Product summary
15.5.4. Recent developments
15.6. GBI
15.6.1. Company details
15.6.2. Financial outlook
15.6.3. Product summary
15.6.4. Recent developments
15.7. LifeCell International Pvt. Ltd.
15.7.1. Company details
15.7.2. Financial outlook
15.7.3. Product summary
15.7.4. Recent developments
15.8. Lonza
15.8.1. Company details
15.8.2. Financial outlook
15.8.3. Product summary
15.8.4. Recent developments
15.9. Merck KGaA
15.9.1. Company details
15.9.2. Financial outlook
15.9.3. Product summary
15.9.4. Recent developments
15.10. Reliance Life Sciences
15.10.1. Company details
15.10.2. Financial outlook
15.10.3. Product summary
15.10.4. Recent developments
15.11. SGS Life Sciences
15.11.1. Company details
15.11.2. Financial outlook
15.11.3. Product summary
15.11.4. Recent developments
15.12. Texcell
15.12.1. Company details
15.12.2. Financial outlook
15.12.3. Product summary
15.12.4. Recent developments
15.13. Wuxi Apptec
15.13.1. Company details
15.13.2. Financial outlook
15.13.3. Product summary
15.13.4. Recent developments
15.14. Others
16. List of Abbreviations
17. Reference Links
18. Conclusion
19. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
